Latest News

Keck Medicine of USC participates in clinical trial to evaluate antiviral drug as possible COVID-19 treatment




Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.

Source link

Related posts

EUSA Pharma und das italienische Krankenhaus Papa Giovanni XXIII veröffentlichen Zwischenanalysedaten zu mit Siltuximab behandelten COVID-19-Patienten aus der SISCO-Studie

Newsemia

Ville durable, ville mutable : quelle convergence en France et en Suisse ?

Newsemia

Spain looks at Italy for clues to deal with new coronavirus

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World